1. X
  2. OncoAlert
Log inSign up
OncoAlert
123.3K posts
Image
user avatar
OncoAlert
@OncoAlert
🌐 Worldwide oncology professionals network | Run by oncologists, for colleagues | All tumor types | Non-profit 🚨 We are #OncoAlert | Oncology360°
Worldwide
OncoAlert360.com
Joined March 2019
137
Following
42.1K
Followers
RepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • Pinned
    user avatar
    OncoAlert
    @OncoAlert
    6h
    For patients with ALK-positive lung cancer, surgery may remove the tumor—but it does not eliminate the threat of relapse. The ELEVATE Trial out in NEJM The #WeekInOncology by @OncoAlert 🚨 Dr. Uğur Özkerim 🇹🇷 breaks down his top #LungCancer 🫁 picks: @peters_solange
    Image
    00:00
    1K01K
  • OncoAlert reposted
    user avatar
    Kidney Cancer
    @KidneyCancer
    1h
    Excited to join @fredhutch once more for their annual kidney cancer patient education symposium. Our Sr. Director of Patient Programs - Amy Marbaugh - will be speaking! Register 👇
    user avatar
    Fred Hutch Cancer Center
    @fredhutch
    Jul 19
    Patients, caregivers and advocates are invited to attend the Kidney Cancer Patient and Caregiver Education Symposium hosted by Fred Hutch Cancer Center in partnership with @KidneyCancer, @kidneycan, and @@smart_patients. Register: bit.ly/4waS6Xm
    Image
    2470247
  • OncoAlert reposted
    user avatar
    Erman Akkus
    @Erman_Akkus
    3h
    🏥Optimizing multimodality sequencing in HCC #cancer #oncology #MedX #liver @OncoAlert
    Image
    Made with AI
    6280628
  • OncoAlert reposted
    user avatar
    ACS Journal Cancer
    @JournalCancer
    1h
    Different presentation phenotypes exhibit distinct clinicopathologic characteristics & have prognostic impact in ES-HL. Further studies integrating molecular profiling are warranted to elucidate root mechanisms & refine risk group allocation. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert
    Image
    Prognostic impact of presentation phenotypes in early‐stage favorable Hodgkin lymphoma
    From acsjournals.onlinelibrary.wiley.com
    1780178
  • OncoAlert reposted
    user avatar
    Vilma P. Barcia MD, PhD, MSc
    @DrVilmaPBarcia
    Jul 15
    Thank you @OncoAlert for sharing!!!
    user avatar
    OncoAlert
    @OncoAlert
    Jul 15
    Could a New Era Be Emerging for Metastatic Pancreatic Cancer? EMA Fast-Tracks Daraxonrasib Review The @OncoAlert 🚨 #WeekInOncology in GI Cancer is here and we proudly introduce Dr. Vilma Barcia🇪🇸 who guides us through Two New publications and great news from the EMA (Links to
    Image
    00:00
    1.2K01.2K
  • OncoAlert reposted
    user avatar
    Dra. María Natalia Gandur Quiroga
    @nataliagandur
    Jul 13
    ⏰ Does the timing of immunotherapy really matter? This week's #WeekInOncology by @OncoAlert 🚨 features an outstanding review by our AF colleague @MarioBalsaMD 🇪🇸, who breaks down the latest evidence in #Melanoma with his trademark clarity and clinical insight. 📄 Discussing
    user avatar
    OncoAlert
    @OncoAlert
    Jul 13
    🕒 Does the time of day of immunotherapy matter? It is NOW time for This #WeekInOncology by @OncoAlert 🚨, this time with our AF colleague @MarioBalsaMD 🇪🇸Discussing the latest in #Melanoma A multicenter analysis of 628 patients with high-risk #melanoma treated with adjuvant
    Image
    00:00
    9610961
  • OncoAlert reposted
    user avatar
    ACS Journal Cancer
    @JournalCancer
    4h
    Have the clinical signs of a serious type of blood cancer changed? 🩸 Study indicates the need for a revised definition of functional high risk #MultipleMyeloma. 🔗: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert @WileyHealth @End_myeloma #MMSM
    Image
    3410341
  • OncoAlert reposted
    user avatar
    Dr Rishabh Jain
    @DrRishabhOnco
    4h
    🚨 Can AI predict who will develop complications after gastric cancer surgery? A new multimodal deep learning model, DeepComp, may bring us closer. Key findings: 🔹 5,237 patients from 11 centers + validation in 6 prospective clinical trials 🔹 Predicts Clavien-Dindo ≥II
    Image
    6700670
  • OncoAlert reposted
    user avatar
    CA: A Cancer Journal for Clinicians
    @CACancerJournal
    4h
    An accompanying editorial to the @AmericanCancer Global Cancer Statistics 2024 report explores why accurate data are the foundation of equitable cancer control and what the latest ovarian cancer statistics reveal. acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… @OncoAlert @StephensonCC @BuffettCancer
    Image
    3210321
  • OncoAlert reposted
    user avatar
    OncoAlert
    @OncoAlert
    Jul 16
    We warmly invite you to join @OncoAlert 🚨 in Lugano, Switzerland🇨🇭 , from April 29 to May 1, 2027, for #LPCCC27 — the Localized Prostate Cancer Consensus Conference. 👉 buff.ly/rgNSNqI 🔗 Register now and be part of #LPCCC27 in Lugano! Building on the success and
    Image
    00:00
    2.1K02.1K
  • OncoAlert reposted
    user avatar
    OncoAlert
    @OncoAlert
    Jul 17
    ¿Qué papel juega Enfortumab Vedotin en el carcinoma urotelial metastásico de vejiga? El Dr. Jorge Pedragosa🇪🇸 (Hospital La Paz, Consorcio GUARD) lo explica en esta nueva Cápsula Educativa de @GuardConsortium 🎥 #GUARD #Oncología #CarcinomaUrotelial @cdanicas @Ecastromarcos
    Image
    00:00
    1K01K
  • user avatar
    OncoAlert
    @OncoAlert
    5h
    Join the 27th Annual International Lung Cancer Congress® for a high-impact update on lung cancer care, featuring the latest in immunotherapy, targeted therapy, ADCs, and multidisciplinary management. (HYBRID: OnLine & OnSite) 👉 REGISTER FREE with code OncoAlert.
    Image
    5310531
  • OncoAlert reposted
    user avatar
    OncoAlert
    @OncoAlert
    Jul 16
    More patients alive and cancer-free at 2 years — adjuvant ensartinib beats placebo in resected ALK+ #NSCLC 🫁 REGISTER to Get the full Newsletter 👉 buff.ly/X6N7qLU or buff.ly/4xd4naf 🫁 Adjuvant ensartinib slashes recurrence risk in resected ALK+ NSCLC (HR
    Image
    00:00
    6.1K06.1K
  • OncoAlert reposted
    user avatar
    OncoAlert
    @OncoAlert
    Jul 16
    ⚽ Spain or Argentina in the World Cup Final? While the world debates that, @Uromigos has its own WorldCUP up for grabs 🌐The Amazing @brian_rini & @tompowles1 (The @Uromigos ) Give us a preview ofeverything coming to 🎸Nashville🇺🇸 this November 13–14, 2026 for #UromigosLIVE and
    Image
    00:00
    5.3K05.3K
Advertisement
Advertisement